21 August 2024

Circulars No.6557 and No.6554for the year 2024 regarding Lifting the Recall of Pharmaceutical Product and Field Safety Corrective Actions

Reference: CIR-2024-00000152

To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Circular No. 6554 for the year 2024 regarding Lifting the Recall of Pharmaceutical Product Rezzayo 200mg vial

&

Circular No. 6557 for the year 2024 regarding Field Safety Corrective Actions

 

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Rezzayo 200mg vial +رفع سحب المنتج الطبي.pdf:

View Document

تقارير سلامة الوسائل الطبية ++15-08-2024.pdf:

View Document